-
Something wrong with this record ?
Expression of beta-catenin is regulated by PI-3 kinase and sodium butyrate in colorectal cancer cells
Turecková J, Kucerová D, Vojtechová M, Sloncová E, Tuhácková Z.
Language English Country Greece
NLK
Free Medical Journals
from 2006 to 1 year ago
Freely Accessible Science Journals
from 2006
- MeSH
- Adenocarcinoma metabolism MeSH
- Alkaline Phosphatase metabolism MeSH
- Androstadienes metabolism MeSH
- beta Catenin genetics metabolism MeSH
- Butyrates metabolism MeSH
- Financing, Organized MeSH
- Phosphatidylinositol 3-Kinases metabolism MeSH
- Phosphorylation MeSH
- Immunohistochemistry MeSH
- Phosphoinositide-3 Kinase Inhibitors MeSH
- Ribosomal Protein S6 Kinases, 70-kDa metabolism MeSH
- Ribosomal Protein S6 Kinases metabolism MeSH
- Colorectal Neoplasms metabolism MeSH
- Humans MeSH
- Mitogen-Activated Protein Kinases metabolism MeSH
- Cell Line, Tumor MeSH
- Serine metabolism MeSH
- Signal Transduction physiology MeSH
- Tyrosine metabolism MeSH
- Check Tag
- Humans MeSH
beta-catenin has a dual function; it is implicated in intercellular junctions and transcriptional co-activation. Here we examined the regulation of the expression and localization of beta-catenin in HT29 colorectal adenocarcinoma cells. Our results showed that inhibition of PI-3 kinase with wortmannin was accompanied by a considerably reduced expression of beta-catenin. This effect was overcome by butyrate and occurred at the protein level, not at the level of mRNA. Moreover, NaBT significantly increased the phosphorylation of the ribosomal protein, S6, known to participate in the translational control of gene expression. This was accompanied by the increased phosphorylation of p70 S6K and MAPKs, the effector proteins that are upstream of protein S6 in the distinct signaling pathways. These facts indicate that different signaling pathways may be involved in the regulation of beta-catenin synthesis. Modulation of beta-catenin expression induced by NaBT appeared to occur at the level of protein translation, suggesting that NaBT may act as a translational regulator.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07520278
- 003
- CZ-PrNML
- 005
- 20111210131046.0
- 008
- 090331s2006 gr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Turečková, Jolana $7 xx0128864
- 245 10
- $a Expression of beta-catenin is regulated by PI-3 kinase and sodium butyrate in colorectal cancer cells / $c Turecková J, Kucerová D, Vojtechová M, Sloncová E, Tuhácková Z.
- 314 __
- $a Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, 166 37 Prague 6, Czech Republic. turejo@img.cas.cz
- 520 9_
- $a beta-catenin has a dual function; it is implicated in intercellular junctions and transcriptional co-activation. Here we examined the regulation of the expression and localization of beta-catenin in HT29 colorectal adenocarcinoma cells. Our results showed that inhibition of PI-3 kinase with wortmannin was accompanied by a considerably reduced expression of beta-catenin. This effect was overcome by butyrate and occurred at the protein level, not at the level of mRNA. Moreover, NaBT significantly increased the phosphorylation of the ribosomal protein, S6, known to participate in the translational control of gene expression. This was accompanied by the increased phosphorylation of p70 S6K and MAPKs, the effector proteins that are upstream of protein S6 in the distinct signaling pathways. These facts indicate that different signaling pathways may be involved in the regulation of beta-catenin synthesis. Modulation of beta-catenin expression induced by NaBT appeared to occur at the level of protein translation, suggesting that NaBT may act as a translational regulator.
- 650 _2
- $a fosfatidylinositol-3-kinasy $x metabolismus $7 D019869
- 650 _2
- $a adenokarcinom $x metabolismus $7 D000230
- 650 _2
- $a alkalická fosfatasa $x metabolismus $7 D000469
- 650 _2
- $a androstadieny $x metabolismus $7 D000730
- 650 _2
- $a butyráty $x metabolismus $7 D002087
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a kolorektální nádory $x metabolismus $7 D015179
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a mitogenem aktivované proteinkinasy $x metabolismus $7 D020928
- 650 _2
- $a fosforylace $7 D010766
- 650 _2
- $a kinasy ribozomálního proteinu S6 $x metabolismus $7 D019893
- 650 _2
- $a kinasy ribozomálního proteinu S6, 70-kDa $x metabolismus $7 D038762
- 650 _2
- $a serin $x metabolismus $7 D012694
- 650 _2
- $a signální transdukce $x fyziologie $7 D015398
- 650 _2
- $a tyrosin $x metabolismus $7 D014443
- 650 _2
- $a beta-katenin $x genetika $x metabolismus $7 D051176
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a inhibitory fosfoinositid-3-kinasy $7 D000081082
- 700 1_
- $a Kučerová, Dana $7 xx0128676
- 700 1_
- $a Vojtěchová, Martina $7 xx0129054
- 700 1_
- $a Šloncová, Eva $7 jk01130483
- 700 1_
- $a Tuháčková, Zdena, $d 1943- $7 xx0128862
- 773 0_
- $w def $t International Journal of Molecular Medicine $g Roč. 17, č. 1 (2006), s. 69-75 $x 1107-3756
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090325104238 $b ABA008
- 991 __
- $a 20090713155711 $b ABA008
- 999 __
- $a ok $b bmc $g 638081 $s 490879
- BAS __
- $a 3
- BMC __
- $a 2006 $b 17 $c 1 $d 69-75 $m International Journal of Molecular Medicine $x MED00173213
- LZP __
- $a 2009-B1/dkme